Cartesian Therapeutics Inc. (NASDAQ: RNAC) Stock Information | RedChip

Cartesian Therapeutics Inc. (NASDAQ: RNAC)


$17.5200
+0.9000 ( +5.80% ) 30.2K

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Market Data


Open


$17.5200

Previous close


$16.6200

Volume


30.2K

Market cap


$446.29M

Day range


$16.7400 - $17.8000

52 week range


$11.6650 - $41.8700

SEC Filings


Form Type Description Pages Date
pre Proxies and info statements 4 Aug 02, 2024
4 Insider transactions 1 Jul 05, 2024
4 Insider transactions 1 Jul 03, 2024
3 Insider transactions 5 Jul 03, 2024
8-k 8K-related 50 Jul 02, 2024
8-k 8K-related 13 Jun 17, 2024
8-k 8K-related 15 May 22, 2024
8-k 8K-related 46 May 08, 2024
10-q Quarterly Reports 107 May 08, 2024
def Proxies and info statements 15 Apr 26, 2024

Latest News